These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 21198996)

  • 21. Analysis of P161NK4A protein expression in follicular thyroid tumors.
    Ferenc T; Lewiński A; Lange D; Niewiadomska H; Sygut J; Sporny S; Jarzab B; Sałacińska-Loś E; Kulig A; Włoch J
    Pol J Pathol; 2004; 55(4):143-8. PubMed ID: 15757201
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Tumor markers in the cytodiagnosis of thyroid nodules. Detection of dipeptidyl aminopeptidase IV (DAP IV) activity].
    Zoro P; Vassko V; Garcia S; Pazart L; Aho S; De Micco C
    Ann Pathol; 1996 Sep; 16(4):261-5. PubMed ID: 9172614
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Can fine-needle aspiration biopsy of thyroid nodule help in determining the extent of surgery in follicular and Hurthle cell neoplasm at a community teaching institution?
    Hawasli A; Rizzo P; Khoury H; McCaffrey JL
    Am Surg; 2002 Oct; 68(10):907-10. PubMed ID: 12412723
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aerodigestive tract invasion by well-differentiated thyroid carcinoma: diagnosis, management, prognosis, and biology.
    McCaffrey JC
    Laryngoscope; 2006 Jan; 116(1):1-11. PubMed ID: 16481800
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Galectin-3 does not reliably distinguish benign from malignant thyroid neoplasms.
    Mehrotra P; Okpokam A; Bouhaidar R; Johnson SJ; Wilson JA; Davies BR; Lennard TW
    Histopathology; 2004 Nov; 45(5):493-500. PubMed ID: 15500653
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Telomerase activity in "suspicious" thyroid cytology.
    Lerma E; Mora J
    Cancer; 2005 Dec; 105(6):492-7. PubMed ID: 16104043
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Computerized morphometric study on fine needle aspirates of cellular follicular lesions of the thyroid.
    Tseleni-Balafouta S; Kavantzas N; Paraskevakou H; Davaris P
    Anal Quant Cytol Histol; 2000 Aug; 22(4):323-6. PubMed ID: 10965408
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beta- and gamma-catenin expression in thyroid carcinomas.
    Cerrato A; Fulciniti F; Avallone A; Benincasa G; Palombini L; Grieco M
    J Pathol; 1998 Jul; 185(3):267-72. PubMed ID: 9771480
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunohistochemical analysis of nm23 protein expression in thyroid papillary carcinoma and follicular neoplasm.
    Tabriz HM; Adabi Kh; Lashkari A; Heshmat R; Haghpanah V; Larijani B; Tavangar SM
    Pathol Res Pract; 2009; 205(2):83-7. PubMed ID: 18996649
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical significance of Hürthle cell in the cytology of thyroid disease].
    Venditti A; Trinti B; Danese D; Centanni M; Messina G; Andreoli M
    Recenti Prog Med; 1997 Jun; 88(6):269-72. PubMed ID: 9289762
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Expression of E-cadherin in thyroid neoplastic tissues and its correlation with malignant and metastatic potential].
    Naitoh A; Kobayashi S; Iwase H; Kuzushima T
    Nihon Rinsho; 1995 Jul; 53(7):1619-22. PubMed ID: 7629998
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A comparative study of cytological and histological studies of the thyroid gland].
    Emmrich P; Gauer G; Gauer J; Mättig H; Rosenkranz M
    Zentralbl Chir; 2001 Apr; 126(4):267-72. PubMed ID: 11370387
    [TBL] [Abstract][Full Text] [Related]  

  • 33. p53 protein, PCNA staining, and DNA content in follicular neoplasms of the thyroid gland.
    Czyz W; Joensuu H; Pylkkänen L; Klemi PJ
    J Pathol; 1994 Dec; 174(4):267-74. PubMed ID: 7884588
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The "cold" nodule of the thyroid gland: 20 years experience with 2,071 patients and diagnostic limits of fine needle biopsy].
    Raber W; Kmen E; Kaserer K; Waldhäusl W; Vierhapper H
    Wien Klin Wochenschr; 1997 Feb; 109(4):116-22. PubMed ID: 9157722
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of cyclin D1 and retinoblastoma protein immunoreactivity in follicular thyroid tumors.
    Ferenc T; Lewiński A; Lange D; Niewiadomska H; Sygut J; Sporny S; Jarzab B; Satacińska-Los E; Kulig A; Włoch J
    Pol J Pathol; 2005; 56(1):27-35. PubMed ID: 15921011
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic value of E-cadherin expression in thyroid follicular carcinoma.
    Brecelj E; Frković Grazio S; Auersperg M; Bracko M
    Eur J Surg Oncol; 2005 Jun; 31(5):544-8. PubMed ID: 15922891
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Planimetric studies on fine needle aspirates from follicular adenoma and follicular carcinoma of the thyroid.
    Boon ME; Löwhagen T; Willems JS
    Acta Cytol; 1980; 24(2):145-8. PubMed ID: 6989141
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Classification of follicular thyroid tumors by molecular signature: results of gene profiling.
    Barden CB; Shister KW; Zhu B; Guiter G; Greenblatt DY; Zeiger MA; Fahey TJ
    Clin Cancer Res; 2003 May; 9(5):1792-800. PubMed ID: 12738736
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in integrin and E-cadherin expression in neoplastic versus normal thyroid tissue.
    Serini G; Trusolino L; Saggiorato E; Cremona O; De Rossi M; Angeli A; Orlandi F; Marchisio PC
    J Natl Cancer Inst; 1996 Apr; 88(7):442-9. PubMed ID: 8618236
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differentiating between benign follicular nodules and follicular neoplasms in thyroid liquid-based cytology preparations.
    Suzuki A; Hirokawa M; Higuchi M; Takada N; Yamao N; Kuma S; Miyauchi A
    Diagn Cytopathol; 2016 Aug; 44(8):659-64. PubMed ID: 27253911
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.